BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12151149)

  • 1. Cytologic and biopsy findings leading to conization in adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Obstet Gynecol; 2002 Aug; 100(2):271-6. PubMed ID: 12151149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?
    Kietpeerakool C; Srisomboon J; Prompittayarat W; Kanjanavaha P; Peuwsai R; Dheerakul C
    Asian Pac J Cancer Prev; 2006; 7(4):522-4. PubMed ID: 17250421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
    Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
    J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases.
    Qizilbash AH
    Am J Clin Pathol; 1975 Aug; 64(2):155-70. PubMed ID: 1155380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix.
    Shipman SD; Bristow RE
    Curr Opin Oncol; 2001 Sep; 13(5):394-8. PubMed ID: 11555719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of diagnoses of endocervical glandular abnormalities in cervical smears.
    Segal A; Frost FA; Miranda A; Fletcher C; Sterrett GF
    Pathology; 2003 Jun; 35(3):198-203. PubMed ID: 14506961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
    Tay EH; Yew WS; Ho TH
    Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.
    Lea JS; Shin CH; Sheets EE; Coleman RL; Gehrig PA; Duska LR; Miller DS; Schorge JO
    Gynecol Oncol; 2002 Oct; 87(1):129-32. PubMed ID: 12468353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold knife versus laser cone biopsy for adenocarcinoma in situ of the cervix--a comparison of management and outcome.
    Dalrymple C; Valmadre S; Cook A; Atkinson K; Carter J; Houghton CR; Russell P
    Int J Gynecol Cancer; 2008; 18(1):116-20. PubMed ID: 17506846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears.
    Novotny DB; Maygarden SJ; Johnson DE; Frable WJ
    Acta Cytol; 1992; 36(1):1-10. PubMed ID: 1546503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
    Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
    Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic conization of the cervix: review of 460 consecutive cases.
    Killackey MA; Jones WB; Lewis JL
    Obstet Gynecol; 1986 Jun; 67(6):766-70. PubMed ID: 3703403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic follow-up of atypical endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear.
    Wang N; Emancipator SN; Rose P; Rodriguez M; Abdul-Karim FW
    Acta Cytol; 2002; 46(3):453-7. PubMed ID: 12040636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma in situ of the cervix.
    Schoolland M; Segal A; Allpress S; Miranda A; Frost FA; Sterrett GF
    Cancer; 2002 Dec; 96(6):330-7. PubMed ID: 12478680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.